BIOMAT Database Logo BIOMAT Database Logo

Changes in maternal plasma macrophage-colony stimulating factor levels during normal pregnancy. 1995

D P Tsakonas, and K H Nicolaides, and C P Tsakona, and C P Worman, and A H Goldstone
Harris Birthright Research Centre for Fetal Medicine, King's College Hospital School of Medicine, London, UK.

An enzyme-like immunosorbent assay and a blood autoanalyser were used to determine macrophage-colony stimulating factor (M-CSF) levels and the absolute number and percentage of circulating monocytes in 80 normal women with singleton pregnancies at 12-40 weeks' gestation, and ten healthy non-pregnant volunteers. The mean values of M-CSF and absolute number and percentage of circulating monocytes of the control group were 367 U/ml (SD 43) and 389 x 10(6)/l (SD 180) and 5.3% (SD 1.7) respectively. In pregnancy, M-CSF was significantly higher than non-pregnant controls only after 28 weeks' gestation. The absolute number and the percentage of circulating monocytes increased significantly with gestation after 16 weeks. There was no significant association between the concentration of M-CSF and the number or percentage of circulating monocytes. These data suggest that during pregnancy there is an up-regulation of M-CSF and monocytes.

UI MeSH Term Description Entries
D007958 Leukocyte Count The number of WHITE BLOOD CELLS per unit volume in venous BLOOD. A differential leukocyte count measures the relative numbers of the different types of white cells. Blood Cell Count, White,Differential Leukocyte Count,Leukocyte Count, Differential,Leukocyte Number,White Blood Cell Count,Count, Differential Leukocyte,Count, Leukocyte,Counts, Differential Leukocyte,Counts, Leukocyte,Differential Leukocyte Counts,Leukocyte Counts,Leukocyte Counts, Differential,Leukocyte Numbers,Number, Leukocyte,Numbers, Leukocyte
D009000 Monocytes Large, phagocytic mononuclear leukocytes produced in the vertebrate BONE MARROW and released into the BLOOD; contain a large, oval or somewhat indented nucleus surrounded by voluminous cytoplasm and numerous organelles. Monocyte
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D011261 Pregnancy Trimester, First The beginning third of a human PREGNANCY, from the first day of the last normal menstrual period (MENSTRUATION) through the completion of 14 weeks (98 days) of gestation. Early Placental Phase,Pregnancy, First Trimester,Trimester, First,Early Placental Phases,First Pregnancy Trimester,First Pregnancy Trimesters,First Trimester,First Trimester Pregnancies,First Trimester Pregnancy,First Trimesters,Phase, Early Placental,Phases, Early Placental,Placental Phase, Early,Placental Phases, Early,Pregnancies, First Trimester,Pregnancy Trimesters, First,Trimesters, First
D011262 Pregnancy Trimester, Second The middle third of a human PREGNANCY, from the beginning of the 15th through the 28th completed week (99 to 196 days) of gestation. Midtrimester,Pregnancy, Second Trimester,Trimester, Second,Midtrimesters,Pregnancies, Second Trimester,Pregnancy Trimesters, Second,Second Pregnancy Trimester,Second Pregnancy Trimesters,Second Trimester,Second Trimester Pregnancies,Second Trimester Pregnancy,Second Trimesters,Trimesters, Second
D011263 Pregnancy Trimester, Third The last third of a human PREGNANCY, from the beginning of the 29th through the 42nd completed week (197 to 294 days) of gestation. Pregnancy, Third Trimester,Trimester, Third,Last Trimester,Last Trimesters,Pregnancies, Third Trimester,Pregnancy Trimesters, Third,Third Pregnancy Trimester,Third Pregnancy Trimesters,Third Trimester,Third Trimester Pregnancies,Third Trimester Pregnancy,Third Trimesters,Trimester, Last,Trimesters, Last,Trimesters, Third
D012016 Reference Values The range or frequency distribution of a measurement in a population (of organisms, organs or things) that has not been selected for the presence of disease or abnormality. Normal Range,Normal Values,Reference Ranges,Normal Ranges,Normal Value,Range, Normal,Range, Reference,Ranges, Normal,Ranges, Reference,Reference Range,Reference Value,Value, Normal,Value, Reference,Values, Normal,Values, Reference
D003430 Cross-Sectional Studies Studies in which the presence or absence of disease or other health-related variables are determined in each member of the study population or in a representative sample at one particular time. This contrasts with LONGITUDINAL STUDIES which are followed over a period of time. Disease Frequency Surveys,Prevalence Studies,Analysis, Cross-Sectional,Cross Sectional Analysis,Cross-Sectional Survey,Surveys, Disease Frequency,Analyses, Cross Sectional,Analyses, Cross-Sectional,Analysis, Cross Sectional,Cross Sectional Analyses,Cross Sectional Studies,Cross Sectional Survey,Cross-Sectional Analyses,Cross-Sectional Analysis,Cross-Sectional Study,Cross-Sectional Surveys,Disease Frequency Survey,Prevalence Study,Studies, Cross-Sectional,Studies, Prevalence,Study, Cross-Sectional,Study, Prevalence,Survey, Cross-Sectional,Survey, Disease Frequency,Surveys, Cross-Sectional
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

D P Tsakonas, and K H Nicolaides, and C P Tsakona, and C P Worman, and A H Goldstone
[Plasma macrophage colony-stimulating factor, granulocyte macrophage colony-stimulating factor and granulocyte colony-stimulating factor levels in continuous ambulatory peritoneal dialysis patients].
May 1997, Rinsho byori. The Japanese journal of clinical pathology,
D P Tsakonas, and K H Nicolaides, and C P Tsakona, and C P Worman, and A H Goldstone
Plasma macrophage colony-stimulating factor levels during cardiopulmonary bypass with extracorporeal circulation.
January 1996, Mediators of inflammation,
D P Tsakonas, and K H Nicolaides, and C P Tsakona, and C P Worman, and A H Goldstone
Maternal serum levels of macrophage colony-stimulating factor are associated with adverse pregnancy outcome.
March 2000, European journal of obstetrics, gynecology, and reproductive biology,
D P Tsakonas, and K H Nicolaides, and C P Tsakona, and C P Worman, and A H Goldstone
[The plasma levels of granulocyte-colony stimulating factor and granulocyte-macrophage colony stimulating factor in breast cancer patients].
October 2007, Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego,
D P Tsakonas, and K H Nicolaides, and C P Tsakona, and C P Worman, and A H Goldstone
High serum human macrophage colony-stimulating factor level during pregnancy.
June 1992, International journal of hematology,
D P Tsakonas, and K H Nicolaides, and C P Tsakona, and C P Worman, and A H Goldstone
Changes in blood macrophage colony-stimulating factor levels after cesarean section in normotensive pregnancy and preeclampsia.
July 2002, The American journal of the medical sciences,
D P Tsakonas, and K H Nicolaides, and C P Tsakona, and C P Worman, and A H Goldstone
Serum levels of macrophage colony-stimulating factor in singleton and twin pregnancy.
March 2006, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme,
D P Tsakonas, and K H Nicolaides, and C P Tsakona, and C P Worman, and A H Goldstone
Effects of recombinant human macrophage colony-stimulating factor on plasma cholesterol levels.
February 1991, Blood,
D P Tsakonas, and K H Nicolaides, and C P Tsakona, and C P Worman, and A H Goldstone
Plasma macrophage colony-stimulating factor and P-selectin levels in malaria-associated thrombocytopenia.
February 1997, Thrombosis and haemostasis,
D P Tsakonas, and K H Nicolaides, and C P Tsakona, and C P Worman, and A H Goldstone
[The plasma levels of granulocyte-colony stimulating factor (G-CSF) and macrophage-colony stimulating factor (M-CSF) in breast cancer patients].
August 2006, Polskie Archiwum Medycyny Wewnetrznej,
Copied contents to your clipboard!